|
Monday, July 27, 2009
|
|
The Price for Beautiful Eyelashes
|
In order to get beautiful eyelashes, women traditionally turn to their tube of mascara. Mascara, although relatively cheap, is only a temporary fix and usually involves a mess to remove. Allergan's introduction of Latisse, a prescription eyelash lengthener and thickener, has been praised by many women as an answer to their prayers for beautiful eyes.
"The active ingredient in Latisse is Bimatoprost, a prostaglandin used in the glaucoma drug Lumigan. When doctors saw little old ladies and others taking Lumigan develop Mata Hari eyelashes, researchers began investigating Bimatoprost for its lash-making ability" reports the Memphis Commercial Appeal website.
Latisse may be more expensive than a normal tube of mascara, ranging from 100-200 dollars depending on location. The prescription is FDA approved and is applied just like eyeliner. There are a few side effects, but they generally fade. The product is even being used off-label as an eyebrow thickener.
|
|
|
Friday, February 27, 2009
|
|
Allergen and Cosmetic Dermatology may be Getting a Lift
|
In recent months Allergen (the company that produces Botox), has been struggling to stay afloat in tough financial times. Last quarter share prices and profit slumped. But news is breaking that Allergen and Botox may be making a comeback. Over the past year Botox injections have been experimentally used for headache and migraine relief alongside other non-wrinkle-removal uses.
Business Week reported on this possible lift for Botox and Allergen, "Two things could soon make Allergan's stock move higher: a new application of Botox to treat chronic daily headaches and a new product called Lumigan, a treatment for glaucoma. But it's one of the side effects of Lumigan that could deliver a bounty for Allergan: use of the compound results in longer and thicker eyelashes. As a result, Allergan developed a product called Latisse, which the Food & Drug Administration approved for eyelash enhancement last December. Latisse is applied on the upper eyelid while Lumigan, an eyedrop, is used in the eyes."
If this new use for Botox boosts revenue and profit for Allergen, other possible uses of Botox may begin to get utilized in the future. Research is going on to see if Botox injections can aid in any other way besides cosmetic enhancements.
|
|
|
|
